Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 11 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Larimar Therapeutics, Inc. | 8,153,107 | reported | 27 Feb 2026 | tx 11+25,486,108 |
| BiomX Inc. | 1,611,864 | reported | 21 Apr 2025 | tx 12+21,207,506−11,766 |
| Oncorus, Inc. | 321,551 | reported | 27 Dec 2022 | tx 6−73,384 |
| Mirum Pharmaceuticals, Inc. | 99,325 | reported | 07 Jul 2021 | tx 3−66,675 |
| Q32 Bio Inc. | 0 | reported | 02 Apr 2018 | tx 10+5,227,035−20,931,141 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 27 Feb 2026 | PURCHASE | Larimar Therapeutics, Inc. | 1,084,010 | 5.00 USD | |
| 27 Feb 2026 | PURCHASE | Larimar Therapeutics, Inc. | 2,000,000 | 5.00 USD | |
| 27 Feb 2026 | PURCHASE | Larimar Therapeutics, Inc. | 831,978 | 5.00 USD | anomaly |
| 27 Feb 2026 | PURCHASE | Larimar Therapeutics, Inc. | 1,084,012 | 5.00 USD | |
| 31 Jul 2025 | PURCHASE | Larimar Therapeutics, Inc. | 3,387,529 | 3.20 USD | first after silence |
| 31 Jul 2025 | PURCHASE | Larimar Therapeutics, Inc. | 3,387,539 | 3.20 USD | |
| 31 Jul 2025 | PURCHASE | Larimar Therapeutics, Inc. | 2,599,932 | 3.20 USD | |
| 21 Apr 2025 | GRANT_AWARD | BiomX Inc. | 1,611,864 | — | deriv |
| 21 Apr 2025 | GRANT_AWARD | BiomX Inc. | 1,611,864 | — | deriv |
| 15 Jul 2024 | EXERCISE | BiomX Inc. | 5,883,000 | — | |
| 15 Jul 2024 | EXERCISE | BiomX Inc. | 5,883,000 | — | |
| 15 Jul 2024 | EXERCISE | BiomX Inc. | 5,883 | — | deriv |
| 15 Jul 2024 | EXERCISE | BiomX Inc. | 5,883 | — | deriv |
| 15 Mar 2024 | GRANT_AWARD | BiomX Inc. | 3,055,049 | — | |
| 15 Mar 2024 | GRANT_AWARD | BiomX Inc. | 3,055,049 | — | |
| 15 Mar 2024 | GRANT_AWARD | BiomX Inc. | 13,490 | — | deriv |
| 15 Mar 2024 | GRANT_AWARD | BiomX Inc. | 40,350 | — | deriv |
| 15 Mar 2024 | GRANT_AWARD | BiomX Inc. | 40,350 | — | deriv |
| 15 Mar 2024 | GRANT_AWARD | BiomX Inc. | 13,490 | — | deriv |
| 27 Dec 2022 | SALE | Oncorus, Inc. | 28,977 | 0.27 USD | |
| 27 Dec 2022 | SALE | Oncorus, Inc. | 28,977 | 0.27 USD | |
| 22 Dec 2022 | SALE | Oncorus, Inc. | 909 | 0.28 USD | |
| 27 Dec 2022 | SALE | Oncorus, Inc. | 7,136 | 0.27 USD | |
| 22 Dec 2022 | SALE | Oncorus, Inc. | 3,692 | 0.28 USD | |
| 22 Dec 2022 | SALE | Oncorus, Inc. | 3,693 | 0.28 USD |
2 purchases reported after at least 12 months of silence — most recent on 31 Jul 2025.